• 1. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 2. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 5. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoquinolines and derivatives Isoquinolines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoquinolines and derivatives

Introduction to 7-Methylisoquinolin-6-ol (CAS No: 666735-06-4)

7-Methylisoquinolin-6-ol, identified by the Chemical Abstracts Service Number (CAS No) 666735-06-4, is a significant heterocyclic compound that has garnered considerable attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the isoquinoline family, a class of nitrogen-containing organic compounds that are widely recognized for their diverse biological activities and pharmacological potential. The structural uniqueness of 7-Methylisoquinolin-6-ol lies in its methyl-substituted isoquinoline backbone, which contributes to its distinct chemical properties and biological interactions.

The isoquinoline scaffold is a privileged structure in drug discovery, with numerous derivatives exhibiting antimicrobial, anti-inflammatory, anticancer, and neuroprotective effects. Among these derivatives, 7-Methylisoquinolin-6-ol has emerged as a compound of interest due to its structural similarity to bioactive natural products and synthetic analogs. Its molecular framework, featuring a benzene ring fused to a pyridine ring with a methyl group at the 7-position and a hydroxyl group at the 6-position, imparts specific electronic and steric characteristics that influence its reactivity and binding affinity.

Recent advancements in computational chemistry and molecular modeling have facilitated a deeper understanding of the interactions between 7-Methylisoquinolin-6-ol and biological targets. Studies have demonstrated that this compound can modulate various enzymatic pathways and receptor binding sites, making it a promising candidate for further investigation in drug development. The hydroxyl group at the 6-position serves as a key pharmacophore, enabling hydrogen bonding interactions with polar residues in protein targets, while the methyl group at the 7-position influences the overall shape and hydrophobicity of the molecule.

One of the most compelling aspects of 7-Methylisoquinolin-6-ol is its potential in oncology research. Isoquinoline derivatives have been extensively studied for their ability to inhibit kinases and other enzymes involved in cancer cell proliferation. Preliminary in vitro studies on 7-Methylisoquinolin-6-ol have shown promising results in inhibiting the growth of several cancer cell lines by disrupting critical signaling pathways. These findings align with emerging research trends that highlight the importance of natural product-inspired compounds in developing next-generation anticancer therapies.

The synthesis of 7-Methylisoquinolin-6-ol presents an intriguing challenge for organic chemists due to its complex aromatic system. Traditional synthetic routes often involve multi-step sequences that require careful optimization to achieve high yields and purity. However, recent innovations in catalytic methods and green chemistry principles have provided more efficient pathways for constructing this molecule. For instance, palladium-catalyzed cross-coupling reactions have been employed to introduce the methyl and hydroxyl functional groups with high precision, minimizing unwanted side products.

In addition to its pharmaceutical applications, 7-Methylisoquinolin-6-ol has shown potential in material science research. Its rigid aromatic structure makes it a suitable candidate for developing organic semiconductors and luminescent materials. Researchers are exploring its properties as a building block for conjugated polymers that could be used in optoelectronic devices such as organic light-emitting diodes (OLEDs) and photovoltaic cells. The ability of this compound to exhibit fluorescence under certain conditions also opens avenues for bioimaging applications.

The pharmacokinetic profile of 7-Methylisoquinolin-6-ol is another critical area of investigation. Understanding how this compound is absorbed, distributed, metabolized, and excreted (ADME) is essential for optimizing its therapeutic efficacy and safety. Advanced techniques such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy have been utilized to characterize its metabolic pathways in vivo. These studies have revealed that 7-Methylisoquinolin-6-ol undergoes biotransformation primarily through phase II metabolism, where it forms glucuronide conjugates that are subsequently excreted via bile.

Future directions in the study of 7-Methylisoquinolin-6-ol include exploring its role in neurological disorders. Isoquinoline derivatives have been linked to neuroprotective effects due to their ability to cross the blood-brain barrier and interact with neurotransmitter systems. Preclinical studies are underway to evaluate whether 7-Methylisoquinolin-6-ol can mitigate neurodegenerative conditions such as Alzheimer's disease by inhibiting oxidative stress and inflammation pathways.

The versatility of 7-Methylisoquinolin-6-ol as a chemical scaffold underscores its importance in interdisciplinary research. By leveraging synthetic chemistry innovations, computational modeling techniques, and preclinical investigations, scientists are uncovering new possibilities for this compound across multiple domains. As our understanding of its structure-function relationships continues to evolve, so too will its potential applications in medicine, materials science, and beyond.

• 65200-74-0(7-ISOQUINOLINOL, 6-METHYL-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)